Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
By Staff Reporters
***
An impactful government program is facing an uncertain future. PEPFAR—an acronym for the President’s Emergency Plan for AIDS Relief—was created by former President George W. Bush in 2003 and is credited with saving 25 million lives around the world. Through the program, the US government has invested more than $100 billion in treatment for HIV-AIDS and related illnesses by providing training, medical infrastructure, and antiretroviral drugs. PEPFAR remains the largest commitment by a country to confront a single disease, according to KFF.
Since its inception, PEPFAR has been renewed every five years with bipartisan support. But that wasn’t the case in 2023, as lawmakers let the program expire at the end of September.
CITE: https://www.r2library.com/Resource
COMMENTS APPRECIATED
Thank You
***
***
Share this:
Filed under: "Doctors Only", Drugs and Pharma, Ethics, Health Insurance, Health Law & Policy, Healthcare Finance | Tagged: AIDS, AIDS relief, anti retro virals, HIV, HIV-AIDS, PEPFAR |
The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants 
Leave a comment